Literature DB >> 25473042

Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa.

Romel D Mackelprang1, Mary Carrington2, Katherine K Thomas1, James P Hughes3, Jared M Baeten4, Anna Wald5, Carey Farquhar4, Kenneth Fife6, Mary S Campbell7, Saida Kapiga8, Xiaojiang Gao9, James I Mullins10, Jairam R Lingappa11.   

Abstract

UNLABELLED: We quantified the collective impact of source partner HIV-1 RNA levels, human leukocyte antigen (HLA) alleles, and innate responses through Toll-like receptor (TLR) alleles on the HIV-1 set point. Data came from HIV-1 seroconverters in African HIV-1 serodiscordant couple cohorts. Linear regression was used to determine associations with set point and R(2) to estimate variation explained by covariates. The strongest predictors of set point were HLA alleles (B*53:01, B*14:01, and B*27:03) and plasma HIV-1 levels of the transmitting partner, which explained 13% and 10% of variation in set point, respectively. HLA-A concordance between partners and TLR polymorphisms (TLR2 rs3804100 and TLR7 rs179012) also were associated with set point, explaining 6% and 5% of the variation, respectively. Overall, these factors and genital factors of the transmitter (i.e., male circumcision, bacterial vaginosis, and use of acyclovir) explained 46% of variation in set point. We found that both innate and adaptive immune responses, together with plasma HIV-1 levels of the transmitting partner, explain almost half of the variation in viral load set point. IMPORTANCE: After HIV-1 infection, uncontrolled virus replication leads to a rapid increase in HIV-1 concentrations. Once host immune responses develop, however, HIV-1 levels reach a peak and subsequently decline until they reach a stable level that may persist for years. This stable HIV-1 set point represents an equilibrium between the virus and host responses and is predictive of later disease progression and transmission potential. Understanding how host and virus factors interact to determine HIV-1 set point may elucidate novel mechanisms or biological pathways for treating HIV-1 infection. We identified host and virus factors that predict HIV-1 set point in people who recently acquired HIV-1, finding that both innate and adaptive immune responses, along with factors that likely influence HIV-1 virulence and inoculum, explain ∼46% of the variation in HIV-1 set point.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25473042      PMCID: PMC4338863          DOI: 10.1128/JVI.01573-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  A common polymorphism in TLR3 confers natural resistance to HIV-1 infection.

Authors:  Manuela Sironi; Mara Biasin; Rachele Cagliani; Diego Forni; Mariacristina De Luca; Irma Saulle; Sergio Lo Caputo; Francesco Mazzotta; Juan Macías; Juan A Pineda; Antonio Caruz; Mario Clerici
Journal:  J Immunol       Date:  2011-12-14       Impact factor: 5.422

Review 2.  Host genetic polymorphisms associated with innate immune factors and HIV-1.

Authors:  Magdalena E Sobieszczyk; Jairam R Lingappa; M Juliana McElrath
Journal:  Curr Opin HIV AIDS       Date:  2011-09       Impact factor: 4.283

3.  Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection.

Authors:  Ling Yue; Heather A Prentice; Paul Farmer; Wei Song; Dongning He; Shabir Lakhi; Paul Goepfert; Jill Gilmour; Susan Allen; Jianming Tang; Richard A Kaslow; Eric Hunter
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

Review 4.  HIV and HLA class I: an evolving relationship.

Authors:  Philip J R Goulder; Bruce D Walker
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

5.  HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.

Authors:  Palanee Ammaranond; David J van Bockel; Kathy Petoumenos; Marylin McMurchie; Robert Finlayson; Melanie G Middleton; Miles P Davenport; Vanessa Venturi; Kazuo Suzuki; Linda Gelgor; John M Kaldor; David A Cooper; Anthony D Kelleher
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

6.  Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.

Authors:  Samuel Alizon; Viktor von Wyl; Tanja Stadler; Roger D Kouyos; Sabine Yerly; Bernard Hirschel; Jürg Böni; Cyril Shah; Thomas Klimkait; Hansjakob Furrer; Andri Rauch; Pietro L Vernazza; Enos Bernasconi; Manuel Battegay; Philippe Bürgisser; Amalio Telenti; Huldrych F Günthard; Sebastian Bonhoeffer
Journal:  PLoS Pathog       Date:  2010-09-30       Impact factor: 6.823

7.  Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.

Authors:  Mary S Campbell; James I Mullins; James P Hughes; Connie Celum; Kim G Wong; Dana N Raugi; Stefanie Sorensen; Julia N Stoddard; Hong Zhao; Wenjie Deng; Erin Kahle; Dana Panteleeff; Jared M Baeten; Francine E McCutchan; Jan Albert; Thomas Leitner; Anna Wald; Lawrence Corey; Jairam R Lingappa
Journal:  PLoS One       Date:  2011-03-02       Impact factor: 3.240

8.  CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.

Authors:  Beatriz Mothe; Anuska Llano; Javier Ibarrondo; Jennifer Zamarreño; Mattia Schiaulini; Cristina Miranda; Marta Ruiz-Riol; Christoph T Berger; M José Herrero; Eduard Palou; Montse Plana; Morgane Rolland; Ashok Khatri; David Heckerman; Florencia Pereyra; Bruce D Walker; David Weiner; Roger Paredes; Bonaventura Clotet; Barbara K Felber; George N Pavlakis; James I Mullins; Christian Brander
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

9.  Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.

Authors:  Jairam R Lingappa; Slavé Petrovski; Erin Kahle; Jacques Fellay; Kevin Shianna; M Juliana McElrath; Katherine K Thomas; Jared M Baeten; Connie Celum; Anna Wald; Guy de Bruyn; James I Mullins; Edith Nakku-Joloba; Carey Farquhar; Max Essex; Deborah Donnell; James Kiarie; Bart Haynes; David Goldstein
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

10.  Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis.

Authors:  Jessica L Prince; Daniel T Claiborne; Jonathan M Carlson; Malinda Schaefer; Tianwei Yu; Shabir Lahki; Heather A Prentice; Ling Yue; Sundaram A Vishwanathan; William Kilembe; Paul Goepfert; Matthew A Price; Jill Gilmour; Joseph Mulenga; Paul Farmer; Cynthia A Derdeyn; Jiaming Tang; David Heckerman; Richard A Kaslow; Susan A Allen; Eric Hunter
Journal:  PLoS Pathog       Date:  2012-11-29       Impact factor: 6.823

View more
  11 in total

Review 1.  The impact of host genetic variation on infection with HIV-1.

Authors:  Paul J McLaren; Mary Carrington
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

2.  Large Variations in HIV-1 Viral Load Explained by Shifting-Mosaic Metapopulation Dynamics.

Authors:  Katrina A Lythgoe; François Blanquart; Lorenzo Pellis; Christophe Fraser
Journal:  PLoS Biol       Date:  2016-10-05       Impact factor: 8.029

3.  Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control.

Authors:  István Bartha; Paul J McLaren; Chanson Brumme; Richard Harrigan; Amalio Telenti; Jacques Fellay
Journal:  PLoS Comput Biol       Date:  2017-02-09       Impact factor: 4.475

4.  Effects of schistosomiasis on susceptibility to HIV-1 infection and HIV-1 viral load at HIV-1 seroconversion: A nested case-control study.

Authors:  Jennifer A Downs; Kathryn M Dupnik; Govert J van Dam; Mark Urassa; Peter Lutonja; Dieuwke Kornelis; Claudia J de Dood; Pytsje Hoekstra; Chifundo Kanjala; Raphael Isingo; Robert N Peck; Myung Hee Lee; Paul L A M Corstjens; Jim Todd; John M Changalucha; Warren D Johnson; Daniel W Fitzgerald
Journal:  PLoS Negl Trop Dis       Date:  2017-09-25

5.  Circumcision status at HIV infection is not associated with plasma viral load in men: analysis of specimens from a randomized controlled trial.

Authors:  Stephanie M Davis; Sherri Pals; Chunfu Yang; Elijah Odoyo-June; Joy Chang; Maroya Spalding Walters; Walter Jaoko; Naomi Bock; Larry Westerman; Carlos Toledo; Robert C Bailey
Journal:  BMC Infect Dis       Date:  2018-07-28       Impact factor: 3.090

Review 6.  Interaction of the Host and Viral Genome and Their Influence on HIV Disease.

Authors:  Riley H Tough; Paul J McLaren
Journal:  Front Genet       Date:  2019-01-23       Impact factor: 4.599

7.  Changing Antiretroviral Eligibility Criteria: Impact on the Number and Proportion of Adults Requiring Treatment in Swaziland.

Authors:  Naomi N Bock; Ruth C Emerson; Jason B Reed; Rejoice Nkambule; Deborah J Donnell; George T Bicego; Velephi Okello; Neena M Philip; Peter D Ehrenkranz; Yen T Duong; Janet S Moore; Jessica E Justman
Journal:  J Acquir Immune Defic Syndr       Date:  2016-03-01       Impact factor: 3.731

8.  Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.

Authors:  Peter Hraber; Bette Korber; Kshitij Wagh; Elena E Giorgi; Tanmoy Bhattacharya; S Gnanakaran; Alan S Lapedes; Gerald H Learn; Edward F Kreider; Yingying Li; George M Shaw; Beatrice H Hahn; David C Montefiori; S Munir Alam; Mattia Bonsignori; M Anthony Moody; Hua-Xin Liao; Feng Gao; Barton F Haynes
Journal:  Viruses       Date:  2015-10-21       Impact factor: 5.048

9.  IL-8 Alterations in HIV-1 Infected Children With Disease Progression.

Authors:  Ambili Nair Pananghat; Heena Aggarwal; Somi Sankaran Prakash; Muzamil Ashraf Makhdoomi; Ravinder Singh; Rakesh Lodha; Shakir Ali; Maddur Srinivas; Bimal Kumar Das; Ravindra Mohan Pandey; Sushil Kumar Kabra; Kalpana Luthra
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 10.  HIV and the tuberculosis "set point": how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive disease.

Authors:  Sara C Auld; Bashar S Staitieh
Journal:  Retrovirology       Date:  2020-09-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.